Welcome to Nanotech Germany - Nano in Germany

Principal Office
Nanostart AG
Goethestrasse 26-28
D-60313 Frankfurt am Main
Germany
Phone: (+)49 - 69 21 93 96 00
Fax: (+)49 - 69 21 93 96 150
E-Mail: info@nanostart.de
Web: www.nanostart.de
Contact Person
Mr. Michael FLACH
Investment Associate
Phone: (+)49 - 69 21 93 96 117
Fax: (+)49 - 69 21 93 96 150
E-Mail: inquiry@nanostart.de
39
Branch Office
Nanostart AG Office Berlin
Bleibtreustraße 32
D-10707 Berlin
Germany
Phone: (+)49 - 30 88 71 63 69 10
Fax: (+)49 - 30 88 71 63 69 99
E-Mail: info@nanostart.de
Web: www.nanostart.de
Contact Person
Dr. Hans Joachim DÜRR
Public Relations Manager
Phone: (+)49 - 69 21 93 96 111
Fax: (+)49 - 69 21 93 96 122
E-Mail: presse@nanostart.de
Nanostart AG was founded in 2003 and is now the leading nanotechnology investment company.
It has its head office in Frankfurt, Germany, as well as a branch office in Berlin. In 2008 the
company also established a subsidiary in Singapore.
Nanostart provides venture capital for young, up-and-coming nanotechnology companies
throughout the world. These are companies that develop nanotechnology-based, highly innovative
products or processes that hold the potential to revolutionize existing markets. Nanostart
invests in a wide range of growth phases, from early-stage ventures and start-ups all the way to
established companies pursuing global expansion. The company either invests directly or
through a fund.
Nanostart´s investment activities take a global orientation, and the portfolio companies already
span the nanotechnologically most active regions of the world, generally in innovation-driven
industries such as healthcare, medicine, cleantech, energy, IT and electronics, and new materials.
Nanostart invests not only with its financial capital, but also with its human capital, by making
its commercialization know-how and its expertise available for its portfolio companies. The
portfolio companies also benefit from Nanostart´s extensive global network, including valuable
contacts to commercialization partners, potential customers, R&D institutions and governments.
Nanostart currently holds nine highly innovative companies in its investment portfolio which are
based in Europe (4), the USA (3) and Asia (2). Among these are leaders that promise, with their
nanotech-based products and processes, to solve the most pressing problems of today’s society,
like the fighting of cancer, the environmentally friendly generation of energy, and efficient and
economic water treatment.
Nanostart AG has to date brought five of its holdings to the stock market, two successful exits
through a trade sales and one asset sale.
Recently, MagForce Nanotechnologies AG a majority-owned subsidiary of Nanostart AG, has
received regulatory approval for medical use of its Nano-Cancer® therapy throughout the European
Union. This momentous event marks the world’s first nanoparticle-based cancer treatment
to come to market.
Marco Beckmann is founder and CEO of Nanostart. Together with a highly professional management
team, he coordinates a global network of scientists, entrepreneurs and investors who
work to advance the company’s interests. The investment team of Nanostart consists of experts
with more than 50 years of combined investment and portfolio management experience in renowned
investment and consulting companies. The supervisory board of Nanostart is comprised
of leading industry figures and takes an active role in all strategically important decisions.